RP Management, LLC - EPIZYME INC ownership

Quarter-by-quarter ownership
RP Management, LLC ownership history of EPIZYME INC
ValueSharesWeighting
Q2 2022$46,807,000
-2.0%
31,841,394
+0.0%
18.49%
-4.8%
Q1 2022$47,750,000
+108.4%
31,833,334
+247.3%
19.42%
+102.5%
Q4 2021$22,917,000
-51.2%
9,166,6670.0%9.59%
-56.2%
Q3 2021$46,933,000
-38.4%
9,166,6670.0%21.90%
-41.0%
Q2 2021$76,175,000
-4.6%
9,166,6670.0%37.14%
+23.9%
Q1 2021$79,842,000
-19.8%
9,166,6670.0%29.97%
-1.9%
Q4 2020$99,550,000
-9.0%
9,166,6670.0%30.54%
+86.3%
Q3 2020$109,358,000
-25.7%
9,166,6670.0%16.39%
-42.4%
Q2 2020$147,217,000
+3.5%
9,166,6670.0%28.46%
-35.5%
Q1 2020$142,175,000
-13.3%
9,166,667
+37.5%
44.14%
+19.0%
Q4 2019$164,000,0006,666,66737.08%
Other shareholders
EPIZYME INC shareholders Q3 2023
NameSharesValueWeighting ↓
RP Management, LLC 9,166,667$109,358,00016.39%
Burrage Capital Management LLC 1,002,528$11,960,0009.44%
Foresite Capital Management III, LLC 998,278$11,909,0008.87%
MPM BioImpact LLC 2,854,737$34,057,0008.20%
Palo Alto Investors LP 6,403,600$76,395,0004.19%
Foresite Capital Management II, LLC 862,402$10,288,0002.24%
Redmile Group, LLC 8,311,633$99,158,0001.82%
Pier Capital, LLC 574,299$6,851,0001.00%
Foresite Capital Management I, LLC 243,759$2,908,0000.82%
Rock Springs Capital Management LP 2,551,659$30,441,0000.77%
View complete list of EPIZYME INC shareholders